Pricing
  1. US-listed companies
  2. BIOLASE, INC
  3. Financials
  4. Total non-current liabilities

BIOLASE, INC【BIOLQ】

Market cap
$36.6
P/E ratio
SummaryFinancials
Period EndTotal non-current liabilities (Million USD)YoY (%)
Dec 31, 202313-12.96%
Dec 31, 202215-4.57%
Dec 31, 202116-17.91%
Dec 31, 202020+1045.65%
Dec 31, 20192-84.94%
Dec 31, 201811+3137.29%
Dec 31, 20170-80.99%
Dec 31, 20162-16.13%
Dec 31, 20152+85.62%
Dec 31, 20141+93.53%
Dec 31, 20131-23.13%
Dec 31, 20121-15.90%
Dec 31, 20111

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)